Colorectal Cancer Clinical Trials in Las Vegas, NV

Colorectal Cancer Clinical Trials in Las Vegas, NV

View the best 10 colorectal cancer medical studies in Las Vegas, Nevada. Access promising new therapies by applying to a Las Vegas-based Colorectal Cancer clinical trial.

Trials in Las Vegas, Nevada

Here are the top 10 medical studies for colorectal cancer in Las Vegas, Nevada

Image of Mayo Clinic in Rochester, United States.

da Vinci SP Surgical System

Robotic Surgery

Recruiting1 award
This trial is testing the safety and performance of the da Vinci SP surgical system in complex colorectal procedures.
Image of Wake Forest School of Medicine in Winston-Salem, United States.

Control arm

Recruiting1 award11 criteria
This trial is testing if letting people choose which health questionnaire to fill out leads to more people filling it out and if they find it more acceptable.
Image of Dignity Health St Joseph's Hospital and Medical Center in Phoenix, United States.

Entrectinib

Tyrosine Kinase Inhibitor

Recruiting1 awardPhase 2
This trial is testing a new drug, entrectinib, for patients with different types of solid tumors that have a gene fusion. Patients will be assigned to different groups depending on their tumor type and gene fusion.
Image of HonorHealth Research Institute - Bisgrove in Scottsdale, United States.

Autogene Cevumeran +1 More

Cancer Vaccine

Recruiting1 awardPhase 1
This trial tests a personalized cancer vaccine and an immune-boosting drug in cancer patients. The vaccine teaches the body to attack cancer, while the drug helps immune cells find and kill hidden cancer cells. This approach aims to induce strong anti-tumor responses by selecting suitable vaccines based on the patient's existing immune system.
Image of Univ of Colorado Cancer Center /ID# 231574 in Aurora, United States.

ABBV-400

Monoclonal Antibodies

Recruiting1 awardPhase 1
This trial tests a new drug called ABBV-400 for adults with advanced cancers. The study aims to find the best dose and see how well it works, both alone and with other treatments. Patients will receive the drug through an IV and be closely monitored for effects and side effects.
Image of Exelixis Site #1 in Tucson, United States.

XL092

Recruiting1 awardPhase 1
This trial is testing a new drug called XL092 alone and with other cancer drugs in patients with advanced solid tumors. The goal is to see if these treatments can safely stop or slow tumor growth and help the immune system fight cancer more effectively.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Leucovorin Calcium +4 More

Chemotherapy

Recruiting2 awardsPhase 3
This trial is testing if vitamin D3 along with regular cancer drugs and another drug that helps the immune system can better treat colorectal cancer that has spread. Vitamin D3 may help the body use essential minerals, making the cancer drugs more effective. Vitamin D3 has been shown to slow down cancer cell growth and help them mature, and it has been effective in reducing intestinal tumors in animal studies.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Capivasertib +18 More

Kinase Inhibitor

Recruiting1 awardPhase 2
This trial uses genomic testing to direct cancer treatment. Patients with cancer that has progressed after standard treatment or for which there is no agreed-upon treatment may benefit.
Image of University of South Alabama Mitchell Cancer Institute in Mobile, United States.

5-fluorouracil +2 More

Anti-metabolites

Recruiting1 awardPhase 3
This trial is studying oxaliplatin, leucovorin calcium, and fluorouracil given together with or without celecoxib in treating patients with stage III colon cancer previously treated with surgery.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Eflornithine +1 More

Enzyme Inhibitor

Recruiting1 awardPhase 3
This trial will test a combination of drugs to see if they are effective in reducing the chance of cancer recurrence or developing new cancers.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.